First Time Loading...

C4 Therapeutics Inc
NASDAQ:CCCC

Watchlist Manager
C4 Therapeutics Inc Logo
C4 Therapeutics Inc
NASDAQ:CCCC
Watchlist
Price: 6.74 USD 4.82% Market Closed
Updated: May 5, 2024

C4 Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

C4 Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
C4 Therapeutics Inc
NASDAQ:CCCC
Pre-Tax Income
-$131.2m
CAGR 3-Years
-25%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$6.3B
CAGR 3-Years
23%
CAGR 5-Years
4%
CAGR 10-Years
2%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$1.1B
CAGR 3-Years
-18%
CAGR 5-Years
-33%
CAGR 10-Years
-16%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$4.4B
CAGR 3-Years
12%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$4.2B
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
19%

See Also

What is C4 Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-131.2m USD

Based on the financial report for Dec 31, 2023, C4 Therapeutics Inc's Pre-Tax Income amounts to -131.2m USD.

What is C4 Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-53%

Over the last year, the Pre-Tax Income growth was -2%. The average annual Pre-Tax Income growth rates for C4 Therapeutics Inc have been -25% over the past three years , -53% over the past five years .